rs59966597
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PS1_ModeratePM1PM5PP3_StrongPP5_Very_Strong
The NM_000526.5(KRT14):c.1162C>T(p.Arg388Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000684 in 1,461,432 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R388H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000526.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT14 | NM_000526.5 | c.1162C>T | p.Arg388Cys | missense_variant | 6/8 | ENST00000167586.7 | NP_000517.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRT14 | ENST00000167586.7 | c.1162C>T | p.Arg388Cys | missense_variant | 6/8 | 1 | NM_000526.5 | ENSP00000167586.6 | ||
KRT14 | ENST00000441550.2 | n.109C>T | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
KRT14 | ENST00000476662.1 | n.612C>T | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251362Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135876
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461432Hom.: 0 Cov.: 34 AF XY: 0.00000825 AC XY: 6AN XY: 726996
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:3Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 388 of the KRT14 protein (p.Arg388Cys). This variant is present in population databases (rs59966597, gnomAD 0.0009%). This missense change has been observed in individual(s) with autosomal dominant epidermolysis bullosa (PMID: 7561171, 17039244, 20060687, 26707537). ClinVar contains an entry for this variant (Variation ID: 66306). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KRT14 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg388 amino acid residue in KRT14. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12707098, 22832485). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 03, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 17039244, 26707537, 26432462, 21375516, 25017986, 18704110, 20060687, 7561171, 29784039) - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Oct 03, 2023 | - - |
Skin fragility with non-scarring blistering;C4024876:Palmoplantar blistering Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jan 01, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at